Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: A report from the Children's Oncology Group Study A2971

Blood

Volumn 118, Issue 26, 2011, Pages 6752-6759

  Gamis, Alan S ^a   Alonzo, Todd A ^b   Gerbing, Robert B ^c   Hilden, Joanne M ^d   Sorrell, April D ^e   Sharma, Mukta ^a   Loew, Thomas W ^f   Arceci, Robert J ^g   Barnard, Dorothy ^h   Doyle, John ⁱ   Massey, Gita ^j   Perentesis, John ^k   Ravindranath, Yaddanapudi ^l   Taub, Jeffrey ^l   Smith, Franklin O ^k  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d CHILDREN S HOSPITAL   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF MISSOURI   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h IWK HEALTH CENTRE   (Canada)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ANEMIA; ARTICLE; BLAST CELL; BONE MARROW SUPPRESSION; CHILD; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DOWN SYNDROME; HEPATOMEGALY; HISTORY; HUMAN; HYDROPS; INFANT; LEUKOCYTOSIS; LEUKOPENIA; LIVER FAILURE; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE DISORDER; NEWBORN; NEWBORN DEATH; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL; THROMBOCYTOPENIA; TRANSIENT MYELOPROLIFERATIVE DISORDER; TRISOMY 21;

EID: 84255176504     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-350017     Document Type: Article

References (24)

1. Gamis AS, Hilden JM. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia? J Pediatr Hematol Oncol. 2002;24(1):2-5. (Pubitemid 34094319)
2. Kurahashi H, Hara J, Yumura-Yagi K, et al. Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. Blood. 1991;77(6):1161-1163.
3. Zipursky A, Brown EJ, Christensen H, Doyle J. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med. 1999;19(1):157-67, vii. (Pubitemid 29217322)
4. Pine S, Guo Q, Yin C, Jayabose S, Druschel C, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 2007;110:2128-2131. (Pubitemid 47443931)
5. Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol. 1997;21(1):97-101. (Pubitemid 27247332)
6. Bajwa RPS, Skinner R, Windebank KP, Reid MM. Demographic study of leukaemia presenting within the first 3 months of life in the Northern Health Region of England. J Clin Pathol. 2004;57(2):186-188. (Pubitemid 38177760)
7. Awasthi A, Das R, Varma N, et al. Hematological disorders In Down syndrome: ten-year experience at a tertiary care centre in North India. Pediatr Hematol Oncol 2005:507-512. (Pubitemid 41285884)
8. Zipursky A, Poon A, Doyle J. Leukemia in Down syndrome: a review. Pediatr Hematol Oncol. 1992;9(2):139-149.
9. Hayashi Y, Eguchi M, Sugita K, et al. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood. 1988;72(1):15-23.
10. Weinstein HJ. Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome. Clin Haematol. 1978;7(1):147-154.
11. Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood. 2006;107(12):4606-4613. (Pubitemid 43882604)
12. Homans AC, Verissimo AM, Vlacha V. Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol. 1993;15(4):392-399. (Pubitemid 23320137)
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley and Sons; 1980.
15. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc Ser B. 1972;34:187-220.
16. Klusmann JH, Creutzig U, Zimmermann M, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111(6):2991-2998.
17. Zipursky A, Rose T, Skidmore M, Thorner P, Doyle J. Hydrops fetalis and neonatal leukemia in Down syndrome. Pediatr Hematol Oncol, 1996;13(1):81-87. (Pubitemid 26033421)
18. Al-Kasim F, Doyle J, Massey G, Weinstein H, Zipursky A. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2002;24(1):9-13. (Pubitemid 34094321)
19. Boneva R, Botto L, Moore C, Yang Q, Correa A, Erickson D. Mortality associated with congenital heart defects in the united states: trends and racial disparities, 1979-1997. Circulation. 2001;103:2376-2381. (Pubitemid 32448803)
20. Freeman S, Taft L, Dooley K, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet. 1998;80(3):213-217. (Pubitemid 28533530)
21. Malec E, Mroczek T, Pajak K, Januszewska K, Zdebska E. Results of surgical treatment of congenital heart defects in children with Down syndrome. Pediatr Cardiol. 1999;20:351-354. (Pubitemid 29383374)
22. Yang Q, Rasmussen A, Friedman J. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population based study. Lancet. 2002;359:1019-1025. (Pubitemid 34286539)
23. Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr Hematol Oncol. 1987;4(3):211-230.
24. Pine S, Guo Q, Yin C, et al. Incidence and clinical implications of GATA1 mutations in newborns with Down Syndrome. Blood. 2007;110(6):2128-2131. (Pubitemid 47443931)